Feeling stuck at a task? Relax with choices from this 'dopamine menu'
You are likely accustomed to encountering a range of menus in daily life, but there is one that may be new to you: a dopamine menu.
Mayo Clinic family medicine physician Dr Robert Wilfahrt, an expert in attention-deficit/hyperactivity disorder (ADHD), explains.
'A dopamine menu is a rebranding of what psychologists or healthcare professionals previously called behavioural activation – ways to get yourself to do what's best for you, instead of what you feel like doing in the moment,' he says.
In this case, the best route to getting that tough task done is to step away from it for a minute, do something else that feeds you energy and then dive back into the task.
The purpose?
To stimulate dopamine, a hormone and neurotransmitter in the brain involved in mood, attention, reward and motivation.
It's also known as the 'feel-good hormone'.
Dopamine comes in many forms – reaching for your phone to scroll through social media is an easy and convenient way to get a bit of a lift, but that's not the only option.
What other accessible activities can bring you joy and a happy brain break?
Examples of healthy 'dopamenu' activities include: Going for a brief walk.
Jamming out to your favourite song.
Making a cup of tea.
Petting your dog or cat.
Lighting a candle.
Reaching out to a friend or family member.
'The idea is to break up what you're doing,' says Dr Wilfahrt.
And if the selected menu item is purposeful, you can feel a sense of reward for small progresses.
When are dopamine menus most useful?
If we're not necessarily enthusiastic about the task we've been assigned, we struggle to maintain attention or interest.
We then risk not meeting the expectation or obligation.
We feel bad about it, get flooded with remorse and have an even tougher time completing the task due to that sense of anxiety.
'It can become a vicious cycle,' says Dr Wilfahrt.
'It can be easy to become avoidant when we're in these sort of doom loops.'
So how can you stop this cycle?
Brainstorm. Make a mental or physical list of things you can do to get recentred.
Dr Wilfahrt says that the more recently rebranded concept tends to be targeted to people with ADHD, but anyone would benefit.
ALSO READ: Could I have been suffering from ADHD all this while?
'It's not a bad idea for anybody to know how to best manage energy.
'Sitting still to labour over one idea isn't healthy for anyone.'
And while activities on your dopamine menu are meant to be enjoyable, don't forget to go back to the hard task.
A journey to the dopamine menu is meant to provide a burst of enthusiasm, not to be something that sucks you in.
Consider setting a timer, perhaps for an unusual interval like 13 minutes and 17 seconds.
Enjoy the boost, then get back to the (real) to-do list. – Mayo Clinic News Network/Tribune News Service
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Straits Times
3 hours ago
- New Straits Times
#HEALTH: ADHD — disorder or disruptive behaviour?
JOE is 8 and constantly fidgets or jumps up during class or when he's watching a movie, eating or even reading. He tries to wait his turn but can't stop himself from blurting out answers during lessons and interrupting his friends. He's been told over and over again that he's naughty and not trying hard enough to be better, but he does. He struggles every day to be like his friends but fails. Joe is a typical case of a child with attention deficit/hyperactivity disorder (ADHD) and while symptoms and specific challenges may vary from person to person, the helplessness and the feeling of being misunderstood are a shared struggle for those diagnosed with the condition. In 2020, the Health Ministry estimated that 1.6 per cent to 4.6 per cent of the population had ADHD. However, like many other disorders, it tends to be under-reported, says IMU University clinical psychologist and senior lecturer Dr Serena In. Statistics show that it is more prevalent in boys, who are three to four times more likely to have ADHD compared with girls. However, these figures may not be entirely accurate as girls tend to adapt their behaviours in socially desirable ways, thus leading to fewer diagnoses. WHAT IS ADHD? ADHD is a neuro-developmental disorder that starts in early childhood. It affects how our brain develops and processes things. "It is not a behavioural problem. What happens in the brain affects the way a child functions," says In. There are three types of ADHD — the predominantly hyperactive-impulsive type, the predominantly inattentive type, or a combination of both. The hyperactive-impulsive types have difficulty staying on a task, are always on the go and fidgety. They can't sit still through a lesson, or even a movie. They may also display a lack of self-control. For example, a typical child would be able to learn behaviours such as lining up and taking turns, but a hyperactive-impulsive type will find it very difficult to do so. On the other hand, the inattentive types tend to forget things or lose things, are easily distracted and find it difficult to concentrate. They don't appear to be listening well and lose interest, appear bored or seem like they are daydreaming. "Whichever type of ADHD a child has, they are often dismissed as children with behavioural and discipline issues, and unfortunately, go through life labelled as rude, uncontrollable and naughty." WHAT CAUSES ADHD? Many different factors play a part in how our brains develop. Genetics play a role, with children having a predisposition to ADHD if it runs in the family. There are also environmental factors, such as toxins they were exposed to as children, as well as prenatal factors like medication consumed by a pregnant mother that can expose a foetus to potential hazards. "Expert groups have also advised parents to delay screen time in children for as long as possible. "The increasing speed of movies, constant advertisements and notifications can be overwhelming and over-stimulating, especially for young malleable brains that are still developing." Excessive screen time also means less exercise, less quality sleep and less time for homework, which affects a child's ability to be at their best, she says. Once a diagnosis has been made, doctors can write reference letters to advocate for the accommodation of certain needs, such as longer exam times, to be allowed sit where he or she can get up and move during class without disrupting others, or to be allowed to use fidget toys in class. "We need to manage and support these children effectively instead of just scolding or disciplining them every time," she says. Outside of school, psychological therapy is also essential for addressing related issues like depression or anxiety. Therapy often involves teaching children coping mechanisms, such as expressing their emotion constructively, as well as managing behaviours by using timers and reminders that can help a child stay focused. At home, parents can relook how they organise family life and set up routines and habits, such as structured meal times. Ensuring the house is clean, neat and orderly also helps. "These are little routines and structures that help everyone, but they are especially beneficial for individuals with ADHD."
Malaysian Reserve
5 days ago
- Malaysian Reserve
British Columbia Joins Other Provincial Public Drug Plans Now Reimbursing FOQUEST® on their Formulary for Attention Deficit Hyperactivity Disorder (ADHD)
TORONTO, July 23, 2025 /CNW/ – Elvium Life Sciences is pleased to announce the addition of FOQUEST® (methylphenidate hydrochloride controlled release capsules) to the British Columbia1 PharmaCare formulary and First Nations Health Authority (FNHA) Pharmacy Benefit. With provincial funding in place in British Columbia, FOQUEST® is now reimbursed from coast to coast on all provincial drug plans across Canada. 'Public funding in British Columbia ensures equitable access to ADHD treatments in BC,' said Juanita Beaudry, Executive Director of the Centre for ADHD Awareness (CADDAC) 'This latest approval now provides access across Canada to another treatment option for patients.' British Columbia now joins Alberta2, Saskatchewan3, Manitoba4, Ontario5, Quebec6, Atlantic Canada7,8,9,10, the Non-Insured Health Benefit Plan11 and Correctional Service Canada in providing public formulary coverage for FOQUEST® for the treatment of ADHD in patients aged six years and older. 'Elvium Life Sciences is very pleased that British Columbia has now included Foquest on the BC PharmaCare Formulary to give physicians an additional choice for their ADHD patients who require public coverage,' said Jodan Ratz, Country Medical Director at Elvium Life Sciences. 'We thank the province for its decision which now means that all ADHD patients aged six years of age and older have equivalent access to Foquest should this be the right treatment for them.' See the full Canadian Product Monograph for FOQUEST®12 The Product Monograph for FOQUEST® contains a Serious Warning and Precaution for drug dependence, emphasizing that abuse of FOQUEST® can lead to dependence. Healthcare professionals should assess the risk of abuse prior to prescribing FOQUEST®, including in patients with a history of drug dependence or alcoholism, and monitor for signs of abuse and dependence while patients are on therapy. FOQUEST® is a once-daily, long-acting methylphenidate controlled-release capsule for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients greater than or equal to six years of age. The maximum daily dose of FOQUEST® for children and adolescents (6 to <18 years old) is 70mg, and the maximum daily dose for adults (≥18 years old) is 100 mg. Adverse events observed with FOQUEST® treatment mainly reflect side effects commonly associated with methylphenidate use. Very common adverse events reported by patients treated with FOQUEST® were headache, insomnia, decreased appetite and abdominal pain. Most of the events were mild to moderate in severity. About Elvium Life Sciences Elvium Life Sciences is an independent associated company of Purdue Pharma (Canada), that focuses on specialty pharmaceutical products committed to providing treatment options for patients who suffer from the symptoms of Attention Deficit/Hyperactivity Disorder (ADHD) and products for ophthalmology. For more information, please visit FOQUEST® is a registered trademark of Purdue Pharma and is used under licence. References: 1. Available at: Accessed July 23, 2025 2. Available at: Accessed July 18, 2025 3. Available at: Accessed July 18, 2025 4. Available at: Accessed July 18, 2025 5. Available at: Accessed July 18, 2025 6. Available at: Accessed July 18, 2025 7. Available at: Accessed July 18, 2025 8. Available at: Accessed July 18, 2025 9. Available at: Accessed July 18, 2025 10. Available at: Accessed July 18, 2025 11. Available at: Accessed July 18, 2025. 12. Available at:
The Sun
6 days ago
- The Sun
A digital revolution transforms early assessment
WHEN Shun Matsuzuka was diagnosed as dyslexic at the age of 19, he was pursuing his foundation year at art school in the UK. It came as a total shock to him. As a child he enjoyed learning, but could not quite understand why his grades did not reflect his efforts or his curiousity in learning. 'That discovery at age 19 proved significant, as it helped me understand that my challenges were not due to lack of ability but rather a different way of processing information. It changed how I saw myself and later how I supported others facing similar struggles,' said Shun, who made the decision to move to Malaysia in 2017. He had worked as creative director for a global advertising agency in Japan. It was also a pivotal moment for Shun when he became a father. He preferred his daughter to grow up in a diverse environment, which Malaysia offered, due to its multicultural identity and culture. When his daughter turned 3 years, Shun received a government issued notice from Japan for a standardised developmental check-up in Japan for her. This he then realised was the missing gap in Malaysia, where there was no systematic developmental screening for children in the crucial ages of 3 to 5 years. Why develop a digital tool for assessment? 'After I became a parent, I was determined to build a tool that would help other children like me – before they start falling behind. That determination led to the creation of TOY8, which later when I introduced the screening aspect became known as TOY8 screening,' said Shun, who teamed up with a former Nintendo game director to co-design the app. The digital screening and intervention tool was also built in collaboration with Sunway University, University of Malaya and the Clinical Research Centre (CRC) of Ministry of Health (MOH). Dato' Dr Amar-Singh HSS, Consultant Pediatrician and child disability advocate said, 'Most Malaysian children receive surveillance and screening for developmental disabilities until the age of 18 months, linked to the Ministry of Health's (MOH) primary vaccination programme. Some may opt out to see private pediatricians. 'However, from the age of 2 to 6 years, most children do not receive any routine surveillance or screening. 'Developmental surveillance is also expensive in the private sector and limited. Hence important developmental disabilities such as Autism Spectrum Disorder, intellectual disabilities, attention deficit disorder (ADHD) and other specific learning disabilities, such as dyslexia are not identified. As a result, many children enter school, unable to face the academic challenges. For 2024, MOE reported that 122,000 year one students, which represents 24% of children for that age, lacked the essential skills of reading, writing and counting,' said Dr Amar-Singh. Today TOY8 screening provides parents with an invaluable opportunity to have their child screened; using this AI-powered digital screening tool in preschools so as to identify the children with learning disabilities early. TOY8 is revolutionary due to the time taken to screen the child, in total twenty minutes and the child-centred design and playful interaction is highly engaging for young children to use. Implementation of the TOY8 screening tool The developmental TOY8 screening project has been successfully introduced both in Sarawak and Selangor. The Sarawak state government offered TOY8 the opportunity to pilot the digital screening tool in preschools. In 2024, Shun launched the first pilot programme in Sarawak with 301 children. More than 30 children were identified as needing developmental support. 'We worked closely with local educators and health professionals to provide targeted interventions for each child. In 2025, the programme is expanding to reach 600 children across the state,' said Shun. In Selangor, the system is being spearheaded through organisations such as KEMAS, the community development department, an agency which manages preschools and the Selangor Children's Heritage Foundation, also referred to as Yayasan Warisan Anak Selangor (YAWAS). TOY8 is now preparing to present this Sarawak based model as a regional policy proposal at the 2025 ASEAN Business Summit, to be held in October this year and hosted by Malaysia. 'What began as a local effort has evolved into a globally recognised initiative. Sarawak's model is now seen as a towering initiative of how data and digital innovation can enable inclusive education to function as a full eco-system –integrating health, education and family support,' added Shun.
